General description
INN
Nivolumab
ATC codes
Medicine type
Biological agent
EML status history
First added in 2019
(TRS
1021)
for
Melanoma of skin
Application rejected in 2019
(TRS
1021)
for
Other specified malignant neoplasms of bronchus or lung
Application rejected in 2023
(TRS
1049)
for
Other specified malignant neoplasms of bronchus or lung
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
- Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion